RxDoctor Payments Data

Christina Midkiff, MD

Gynecology · Maryville, ILNPI 1306825856

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.2% of the total across 286 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $877 and has fallen 51.4% since, to $426 in 2025.

$4,204in general payments, 2019–2025

Across 286 payments — averaging $14.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avion Pharmaceuticals$658
  • Mayne Pharma Commercial LLC$567
  • AbbVie$513
  • Organon$178
  • Exeltis, USA Inc.$177
  • Exact Sciences$147
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$4,12998%
  • Education$752%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,204 in reported general payments places this provider in the 70th percentile of 68 gynecology providers in Illinois.

See all gynecology providers in Illinois

Medicare billing

Part B allowed, 2024
$33,218
Medicare patients
336
Services billed
592

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol279$14,982
PremproEstrogen,con/M-Progest Acet27$13,024
PremarinEstrogens, Conjugated22$11,506
EstringEstradiol19$10,019
ProgesteroneProgesterone, Micronized59$3,941
YuvafemEstradiol25$3,766
ValacyclovirValacyclovir Hcl59$3,547
Ibandronate Sodium95$3,454
Raloxifene Hcl47$2,337
Risedronate Sodium21$2,270
Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet21$2,161
Vitamin D2Ergocalciferol (Vitamin D2)146$1,658
Estradiol (Once Weekly)Estradiol19$1,632
Solifenacin Succinate30$1,317
Clobetasol Propionate26$1,264

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPrempro, Premarin, Estring$46$34,55068 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 68 gynecology providers in Illinois.

Other gynecology in Maryville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →